Research Program: Transplant Biology and Therapy
Assistant Professor of Medicine: Hematology, Oncology and Transplantation Division, Department of Medicine, University of Minnesota Medical School

bmcclune@umn.edu

Dr. McClune's clinical profile (University of Minnesota Physicians Web site)

Dr. McClune received his D.O. in 2000 from the College of Osteopathic Medicine, Kansas City University of Medicine and Biosciences. He was in the Sinai Hospital Internal Medicine Program at the John Hopkins School of Medicine in Baltimore from 2000 to 2003; from 2003 to 2006, he completed a hematology/oncology fellowship at the University of Tennessee Health Science Center in Memphis, where he was chief fellow from 2005 to 2006. Dr. McClune came to the University of Minnesota in 2006 to be assistant professor of medicine for the Hematology, Oncology and Transplantation Division, Department of Medicine, Medical School.

Research Interests

Improving multiple myeloma therapies before and after transplantation and clinical trials related to treatment and supportive care of our transplant patients with varied hematologic malignancies.

Selected Publications

Przepiorka D, Buadi FK, McClune B. Oral Voriconazole for Empiric Antifungal Treatment in Uncomplicated Febrile Neutropenic Patients. Pharmacotherapy. 2008 Jan; 28(1): 58-63.

McClune B, Buadi F, Aslam N, Przepiorka D. Intrathecal liposomal cytarabine (Depocyt) is safe and effective for prevention of meningeal disease in patients with acute lymphoblastic leukemia and high-grade lymphoma treated with the hyperCVAD regimen. Leuk Lymphoma. 2007 Sep; 48(9): 1849-51.

Przepiorka D, Buadi F, McClune B et al. Myelodysplasia after Autologous Stem Cell Transplantation for Multiple Myeloma. Bone Marrow Transplant. 2007 Oct;40(8)759-64.